FARBRIDGE PHARMA CONSULTING
LIVE

Serial Number

99258951

Owner

Farbridge Pharma Consulting, LLC

Attorney

Edward N. Benito

First Use Date

Jul 17, 2023

Filing Date

Jun 30, 2025

Add to watchlist:

No watchlists yet
View on USPTO

FARBRIDGE PHARMA CONSULTING Trademark

Serial Number: 99258951 • Registration: 8134452

FARBRIDGE PHARMA CONSULTING is a trademark filed by Farbridge Pharma Consulting, LLC on June 30, 2025. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Farbridge Pharma Consulting, LLC (7 trademarks)

8525 Gibbs Drive, Suite 304
San Diego, CA 92123

Entity Type: 16

Trademark Details

Filing Date

June 30, 2025

Registration Date

February 10, 2026

First Use Anywhere

July 17, 2023

First Use in Commerce

July 17, 2023

Published for Opposition

December 23, 2025

Goods & Services

Consulting services in the field of biotechnology; Consulting services in the field of genetic science; Consulting services in the field of pharmaceutical research and development; Pharmaceutical drug development services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 10, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 23, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 17, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 24, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 24, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 24, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 24, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 24, 2025 CNEA
ASSIGNED TO EXAMINER
Nov 18, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 7, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 30, 2025 MAFR
NEW APPLICATION ENTERED
Jun 30, 2025 NWAP